Bakulin M P, Sil'vestrov V P, Karaulov A V, Martsinovskiĭ V Iu
Ter Arkh. 1987;59(12):33-9.
The paper is concerned with the results of a study of the nature of immunological disorders in 150 patients with chronic bronchitis and preasthma and in 203 patients with bronchial asthma (BA). Subpopulation analysis of immunocompetent cells with the help of monoclonal antibodies permitted the detection of certain differences in the regulatory link of immunity in patients with different types of chronic nonspecific pulmonary diseases. Patients with purulent bronchitis demonstrated a decrease in the level of the population of T-helpers and a tendency to an increase in the level of T-suppressors, whereas preasthmatic patients demonstrated a decrease in the level of T-helpers in parallel with a sharp deficiency of T-suppressors. An analysis of immune disorders in BA patients revealed the same line of immunological shifts as in preasthmatic patients, however a degree of the affection of the suppressor systems was much greater. The study has shown that immune disorders typical of BA, are revealed even at the early stages of disease, i.e. at the preasthmatic stage. Possible immune mechanisms of pathogenesis of chronic bronchitis, preasthma and BA are discussed. A conclusion is made that immunological investigation including the determination of the levels of T-helpers and T-suppressors and their ratios (the so-called immunoregulatory index) in combination with other methods makes it possible to detect persons at risk of developing BA, at the early stages of development of disease. Immunocorrective therapy is recommended to such patients to prevent development of chronic bronchitis into BA.
本文关注的是对150例慢性支气管炎和哮喘前期患者以及203例支气管哮喘(BA)患者免疫紊乱性质的研究结果。借助单克隆抗体对免疫活性细胞进行亚群分析,使得能够检测出不同类型慢性非特异性肺部疾病患者在免疫调节环节上的某些差异。化脓性支气管炎患者表现出T辅助细胞群体水平下降以及T抑制细胞水平有上升趋势,而哮喘前期患者则表现为T辅助细胞水平下降同时伴有T抑制细胞严重缺乏。对BA患者免疫紊乱的分析揭示出与哮喘前期患者相同的免疫变化趋势,然而抑制系统受影响的程度要大得多。该研究表明,BA典型的免疫紊乱在疾病早期即哮喘前期阶段就已显现。文中讨论了慢性支气管炎、哮喘前期和BA发病机制的可能免疫机制。得出的结论是,包括测定T辅助细胞和T抑制细胞水平及其比率(所谓的免疫调节指数)在内的免疫调查,结合其他方法,能够在疾病发展的早期阶段检测出有发展为BA风险的人群。建议对这类患者进行免疫纠正治疗,以防止慢性支气管炎发展为BA。